ERBB2 and breast carcinoma: For genomic alterations, recurrent mutations in breast cancer, such as PIK3CA, TP53, and GATA3, were found in HER2-low breast cancers, and the downstream effects of copy number alterations (CNAs) can also be seen at the RNA and protein levels (Supplementary Fig. S2).